These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38002786)

  • 21. Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.
    Ocak G; Roest M; Verhaar MC; Rookmaaker MB; Blankestijn PJ; Bos WJW; Fijnheer R; Péquériaux NC; Dekker FW
    BMC Nephrol; 2021 Jun; 22(1):222. PubMed ID: 34134634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
    Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
    Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity.
    Dyer MR; Plautz WE; Ragni MV; Alexander W; Haldeman S; Sperry JL; Guyette FX; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Neal MD;
    Transfusion; 2020 Jun; 60(6):1308-1318. PubMed ID: 32441353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating von Willebrand factor and ADAMTS13 levels in thalassemia major patients and assessing a possible association with Thrombospondin-1.
    Al-Sabaan K; Al-Awadhi A
    Int J Lab Hematol; 2023 Dec; 45(6):945-952. PubMed ID: 37438087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis.
    Prasannan N; Heightman M; Hillman T; Wall E; Bell R; Kessler A; Neave L; Doyle A; Devaraj A; Singh D; Dehbi HM; Scully M
    Blood Adv; 2022 Jul; 6(13):4041-4048. PubMed ID: 35543533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
    Larkin D; de Laat B; Jenkins PV; Bunn J; Craig AG; Terraube V; Preston RJ; Donkor C; Grau GE; van Mourik JA; O'Donnell JS
    PLoS Pathog; 2009 Mar; 5(3):e1000349. PubMed ID: 19300493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure.
    Takaya H; Namisaki T; Enomoto M; Kubo T; Tsuji Y; Fujinaga Y; Nishimura N; Kaji K; Kawaratani H; Moriya K; Akahane T; Matsumoto M; Yoshiji H
    Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients.
    Sweeney JM; Barouqa M; Krause GJ; Gonzalez-Lugo JD; Rahman S; Gil MR
    TH Open; 2021 Jan; 5(1):e89-e103. PubMed ID: 33709050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019.
    Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Zgoura P; Witzke O; Dittmer U; Brenner T; Paniskaki K; Yilmaz S; Dittmer R; Schneppenheim S; Wilhelm J; Stervbo U; Babel N; Budde U; Westhoff TH
    Sci Rep; 2023 Jun; 13(1):10501. PubMed ID: 37380654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma.
    Plautz WE; Haldeman SH; Dyer MR; Sperry JL; Guyette FX; Loughran PA; Alvikas J; Hassoune A; Hoteit L; Alsaadi N; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Mota RI; Neal MD;
    Blood Coagul Fibrinolysis; 2022 Jan; 33(1):14-24. PubMed ID: 34889809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand Factor Adhesive Activity and ADAMTS13 Protease Activity in HIV-1-Infected Men.
    Graham SM; Chen J; Le J; Ling M; Chung DW; Liles WC; López JA
    Int J Med Sci; 2019; 16(2):276-284. PubMed ID: 30745808
    [No Abstract]   [Full Text] [Related]  

  • 37. Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.
    Sánchez-Santillán RN; Sierra-Vargas MP; González-Islas D; Aztatzi-Aguilar OG; Pérez-Padilla R; Orea-Tejeda A; Debray-García Y; Ortega-Romero M; Keirns-Davis C; Loaeza-Roman A; Rios-Pereda A
    BMC Pulm Med; 2024 Jul; 24(1):325. PubMed ID: 38965511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
    Islek A; Ilhan D; Ozturk N; Guven B; Sag E
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e951-e956. PubMed ID: 33369998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
    Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
    Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population.
    Wang Z; Dou M; Du X; Ma L; Sun P; Cao H; Ye S; Jiang P; Liu F; Lin F; Zhang R; Li C
    PeerJ; 2017; 5():e3156. PubMed ID: 28382235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.